MedPath

AK-Con

ALBALON (naphazoline hydrochloride ophthalmic solution, USP) 0.1%

Approved
Approval ID

297f0888-729c-4ce6-8779-6b239abf3c93

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 30, 2011

Manufacturers
FDA

Rebel Distributors Corp.

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

naphazoline hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-915
Application NumberANDA083590
Product Classification
M
Marketing Category
C73584
G
Generic Name
naphazoline hydrochloride
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateMay 30, 2006
FDA Product Classification

INGREDIENTS (8)

waterInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CARBONATEInactive
Code: 45P3261C7T
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
BORIC ACIDInactive
Code: R57ZHV85D4
Classification: IACT
sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
naphazoline hydrochlorideActive
Quantity: 1 mg in 1 mL
Code: MZ1131787D
Classification: ACTIB
edetate disodiumInactive
Code: 7FLD91C86K
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AK-Con - FDA Drug Approval Details